Found: 6
Select item for more details and to access through your institution.
Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1010790
- By:
- Publication type:
- Article
Isoforms of the Papillomavirus Major Capsid Protein Differ in Their Ability to Block Viral Spread and Tumor Formation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.811094
- By:
- Publication type:
- Article
The interplay of UV and cutaneous papillomavirus infection in skin cancer development.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 11, p. 1, doi. 10.1371/journal.ppat.1006723
- By:
- Publication type:
- Article
Protective Vaccination against Papillomavirus-Induced Skin Tumors under Immunocompetent and Immunosuppressive Conditions: A Preclinical Study Using a Natural Outbred Animal Model.
- Published in:
- PLoS Pathogens, 2014, v. 10, n. 2, p. 1, doi. 10.1371/journal.ppat.1003924
- By:
- Publication type:
- Article
Cutaneous HPV23 E6 Prevents p53 Phosphorylation through Interaction with HIPK2.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027655
- By:
- Publication type:
- Article
Spatial tissue proteomics reveals distinct landscapes of heterogeneity in cutaneous papillomavirus‐induced keratinocyte carcinomas.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 6, p. 1, doi. 10.1002/jmv.28850
- By:
- Publication type:
- Article